Marjorie Taylor Greene, Representative
buy disclosed on 28 Oct 2025 via House STOCK Act disclosures
- Transaction value
- 1.001 US$
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- 0.0%
Public company research profile
This public-disclosure research profile is not investment advice. It summarizes historical public filings, source links, confidence context, and hypothetical outcomes so readers can verify the evidence themselves.
Company research history
st Cardinal Health, Inc. Common Stock (CAH)
Source-transparent disclosure history for this company, built from public CopyWindow signals and previous hypothetical outcomes.
13 disclosures
6 insiders
0 cluster signals
0.0% avg. 30d outcome
Company facts
- Ticker / ISIN
- CAH / Not available
- Exchange
- Not available
- Country
- US
- Sector
- Not available
Disclosure history
Marjorie Taylor Greene, Representative
buy disclosed on 19 May 2025 via House STOCK Act disclosures
- Transaction value
- 1.001 US$
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- 0.0%
Rob Bresnahan, Representative
buy disclosed on 8 May 2025 via House STOCK Act disclosures
- Transaction value
- 1.001 US$
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- 0.0%
Marjorie Taylor Greene, Representative
buy disclosed on 6 May 2025 via House STOCK Act disclosures
- Transaction value
- 1.001 US$
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- 0.0%
Marjorie Taylor Greene, Representative
buy disclosed on 19 Mar 2025 via House STOCK Act disclosures
- Transaction value
- 1.001 US$
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- 0.0%
Marjorie Taylor Greene, Representative
buy disclosed on 27 Jan 2025 via House STOCK Act disclosures
- Transaction value
- 1.001 US$
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- 0.0%
Marjorie Taylor Mrs Greene, Representative
buy disclosed on 23 Sept 2024 via House STOCK Act disclosures
- Transaction value
- 1.001 US$
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- 0.0%
John James, Representative
sell disclosed on 6 Sept 2024 via House STOCK Act disclosures
- Transaction value
- 1.001 US$
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- 0.0%
John James, Representative
buy disclosed on 2 Sept 2024 via House STOCK Act disclosures
- Transaction value
- 1.001 US$
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- 0.0%
John James, Representative
buy disclosed on 2 Sept 2024 via House STOCK Act disclosures
- Transaction value
- 1.001 US$
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- 0.0%
Jonathan Jackson, Representative
buy disclosed on 15 Feb 2024 via House STOCK Act disclosures
- Transaction value
- Not available
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- 0.0%
Kathy Manning, Representative
sell disclosed on 14 Sept 2022 via House STOCK Act disclosures
- Transaction value
- 1.001 US$
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- 0.0%
Kathy Manning, Representative
buy disclosed on 10 Aug 2022 via House STOCK Act disclosures
- Transaction value
- 1.001 US$
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- 0.0%